Fig. 6

In vivo tracking of mKate2-labeled BM-MSCs during wound repair under pathological conditions. a The appearance of major organs harvested from model rats. b The area of mKate2 staining on the wound at days 3, 7, and 14. c Fluorescence imaging of major organs harvested at days 3, 7, and 14 after transplantation of mKate2-labeled BM-MSCs. d mKate2-labeled BM-MSCs distribution analysis on lung, pancreas, and wound sections at days 3, 7, and 14 posttransplantation via IV and topical, respectively (RFP IHC staining, 40 × 10). Values are mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001